Cargando…

Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in “Omics” Medicine

Renal transplantation represents the most favorable treatment for patients with advanced renal failure and it is followed, in most cases, by a significant enhancement in patients’ quality of life. Significant improvements in one-year renal allograft and patients’ survival rates have been achieved ov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaza, Gianluigi, Granata, Simona, Tomei, Paola, Dalla Gassa, Alessandra, Lupo, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346957/ https://www.ncbi.nlm.nih.gov/pubmed/25690039 http://dx.doi.org/10.3390/ijms16024281

Ejemplares similares

Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen
por: Zaza, Gianluigi, et al.
Publicado: (2017)

Mitochondria: a new therapeutic target in chronic kidney disease
por: Granata, Simona, et al.
Publicado: (2015)

Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease
por: Granata, Simona, et al.
Publicado: (2016)

Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects
por: Zaza, Gianluigi, et al.
Publicado: (2014)

Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors
por: Zaza, Gianluigi, et al.
Publicado: (2013)

Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects
por: Granata, Simona, et al.
Publicado: (2016)

Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients
por: Zaza, Gianluigi, et al.
Publicado: (2014)

Skin cancer in solid organ transplant recipients: still an open problem
por: Granata, Simona, et al.
Publicado: (2023)

mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis
por: Granata, Simona, et al.
Publicado: (2021)

Hairy cell leukemia in kidney transplantation: lesson from a rare disorder
por: Vinante, Fabrizio, et al.
Publicado: (2013)

Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase
por: Masola, Valentina, et al.
Publicado: (2013)

Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease
por: Signorini, Lorenzo, et al.
Publicado: (2017)

How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center
por: Zaza, Gianluigi, et al.
Publicado: (2015)

Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment
por: Gisondi, Paolo, et al.
Publicado: (2020)

Proteomic analysis of urinary extracellular vesicles of kidney transplant recipients with BKV viruria and viremia: A pilot study
por: Bruschi, Maurizio, et al.
Publicado: (2022)

In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets
por: Granata, Simona, et al.
Publicado: (2018)

Inflammasome pathway in kidney transplantation
por: Granata, Simona, et al.
Publicado: (2023)

In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells
por: Masola, Valentina, et al.
Publicado: (2019)

mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation
por: Granata, Simona, et al.
Publicado: (2023)

Massive Necrotizing Pancreatitis in an Immunosuppressed Renal Transplant Recipient (Successful Therapy)
por: Slaton, Joel W., et al.
Publicado: (1993)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
por: Phanish, Mysore K., et al.
Publicado: (2020)

Pacemaker-related Candida parapsilosis fungaemia in an immunosuppressed renal transplant recipient
por: Hebert, Josephine, et al.
Publicado: (2021)

Transplant of kidneys with small renal cell carcinoma in incompatible, heavily immunosuppressed recipients
por: Ali, AM, et al.
Publicado: (2012)

Recalcitrant hyperkeratotic verrucae in a renal transplant recipient clearing with cessation of immunosuppression
por: Maor, Danit, et al.
Publicado: (2018)

Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
por: Kirk, Allan D., et al.
Publicado: (2020)

Renal Outcomes of Liver Transplantation Recipients Receiving Standard Immunosuppression and Early Renal Sparing Immunosuppression: A Retrospective Single Center Study
por: Sharma, Pratima, et al.
Publicado: (2019)

Impact of heparanase on renal fibrosis
por: Masola, Valentina, et al.
Publicado: (2015)

mRNA as a medicine in nephrology: the future is now
por: Granata, Simona, et al.
Publicado: (2023)

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
por: Muduma, Gorden, et al.
Publicado: (2014)

Graft loss among renal-transplant recipients with early reduction of immunosuppression for BK viremia
por: Azar, Marwan M, et al.
Publicado: (2017)

Effect of Immunosuppressive Therapy on the Occurrence of Atypical Hemolytic Uremic Syndrome in Renal Transplant Recipients
por: Raina, Rupesh, et al.
Publicado: (2018)

COVID-19 AND IMMUNOSUPPRESSION: A CASE OF COVID-19 IN A RENAL TRANSPLANT RECIPIENT
por: Boparai, Sukhmani, et al.
Publicado: (2020)

Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project)
por: Rosa, Alessandro C., et al.
Publicado: (2023)

Sphingomyelin and Medullary Sponge Kidney Disease: A Biological Link Identified by Omics Approach
por: Granata, Simona, et al.
Publicado: (2021)

Increased Complement Gene Expression in Circulating B Cells From Kidney Transplant Recipients With Chronic Antibody-Mediated Rejection
por: Cravedi, Paolo, et al.
Publicado: (2022)

Downregulation of Nuclear-Encoded Genes of Oxidative Metabolism in Dialyzed Chronic Kidney Disease Patients
por: Zaza, Gianluigi, et al.
Publicado: (2013)

Pre-Transplant Expression of CCR-2 in Kidney Transplant Recipients Is Associated With the Development of Delayed Graft Function
por: Pontrelli, Paola, et al.
Publicado: (2022)

Validity and reliability of a novel immunosuppressive adverse effects scoring system in renal transplant recipients
por: Meaney, Calvin J, et al.
Publicado: (2014)

Oxidative and Nitrosative Stress in Stable Renal Transplant Recipients with Respect to the Immunosuppression Protocol – Differences or Similarities?
por: Cvetković, Tatjana, et al.
Publicado: (2015)

The Clinical Manifestation of Immunosuppressive Therapy as a Tool to Improve Immune Monitoring in Renal Transplant Recipients
por: Scott, Noa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_in5eeotsi5p3vsgt1i0a5bahk3